Short Summary
The PTAB remand decision held that all 23 claims of Omni MedSci’s wearable pulse‑oximetry patent are unpatentable, applying 35 U.S.C. § 103 obviousness over multiple prior‑art references.
Detailed Summary
In a Final Written Decision on Remand for IPR2021‑00453, the Patent Trial and Appeal Board affirmed the claim‑construction that “identify an object” means to recognize or establish an object as a particular thing. The Board then applied an obviousness analysis under 35 U.S.C. § 103, finding that the combination of prior‑art references—Lisogurski, Carlson, Tran, Isaacson, and Valencell‑093—disclosed each limitation of claims 1 through 23 of Omni MedSci’s wearable pulse‑oximetry patent. Petitioner’s expert testimony demonstrated a motivation to combine these teachings. As a result, all challenged claims were declared unpatentable.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in WHOOP, Inc. vs Omni MedSci, Inc. is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Biocon Biologics Limited et al.vs--
Biocon has filed a PGR petition seeking to invalidate all 38 claims of Regeneron’s ‘036 anti‑VEGF eye‑treatment patent, alleging obviousness over prior art and lack of written description.
Samsung Electronics Co., Ltd. et al.vsNetlist, Inc.
The PTAB held that Samsung and its co‑petitioners proved all 30 claims of Netlist’s ’918 hybrid memory patent obvious over Harris, JEDEC FBDIMM standards, Amidi and Hajeck, resulting in a complete invalidation.
PacifiCorp et al.vsMES, Inc.
An email from the PTAB Director notifies PacifiCorp and MES, Inc. that Director Review requests have been filed for two IPRs. The petitioner has five business days to submit a limited response, and no new evidence may be introduced.
Apple Inc.vsWeCrevention, Inc.
Apple has filed an IPR petition challenging WeCrevention’s DRAM patent (U.S. 10,998,017), asserting that claims 1‑2 are anticipated or obvious over multiple prior‑art DRAM disclosures and that the input/output unit is a §112(f) means‑plus‑function term.
Taiwan Semiconductor Manufacturing Company Ltd.vsAdvanced Integrated Circuit Process LLC
TSMC petitions the PTAB to institute an IPR against Advanced Integrated Circuit Process’s 7,632,751 patent, seeking cancellation of 20 claims covering dummy‑via dual‑damascene methods. The petition relies on multiple grounds of anticipation and obviousness under §§102 and 103.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.